Drug Details
General Information of the Drug (ID: DR1642) | ||||
---|---|---|---|---|
Name |
Pinostrobin
|
|||
Synonyms |
Pinostrobin; 480-37-5; Pinostrombin; Pinocembrin-7-methylether; UNII-SZD9LZS694; SZD9LZS694; CHEMBL254613; (S)-2,3-Dihydro-5-hydroxy-7-methoxy-2-phenyl-4-benzopyrone; CHEBI:80491; (2s)-5-hydroxy-7-methoxyflavanone; 5-Hydroxy-7-methoxy-2-phenyl-2,3-dihydro-4H-chromen-4-one; (2S)-5-hydroxy-7-methoxy-2-phenyl-2,3-dihydrochromen-4-one; pinocembrin-7-methyl ether; dihydrotectochrysin; (-)-pinostrobin; (2S)-pinostrobin; (2S)-5-hydroxy-7-methoxy-2-phenyl-chroman-4-one; SCHEMBL7648566; DTXSID50963979; ZINC391894; Pinostrobin, >=99.0% (TLC); HY-N2127; EINECS 207-548-1; BDBM50338968; (+/-)-5-hydroxy-7-methoxyflavanone; AKOS037515398; CCG-262304; NCGC00163610-01; 5-Hydroxy-7-methoxy-2-phenyl-chroman-4-one; CS-0018678; C16419; 480P375; SR-05000013704; SR-05000013704-1; Q27149542; 5-Hydroxy-7-methoxy-2-phenyl-2,3-dihydro-4H-1-benzopyran-4-one; (2S)-5-hydroxy-7-methoxy-2-phenyl-2,3-dihydro-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 2,3-dihydro-5-hydroxy-7-methoxy-2-phenyl-, (S)-
Click to Show/Hide
|
|||
Molecular Type |
Small molecule
|
|||
Disease | Parkinson's disease [ICD-11: 8A00] | Investigative | [1] | |
Structure |
![]() |
Click to Download Mol2D MOL |
||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
Formula |
C16H14O4
|
|||
PubChem CID | ||||
Canonical SMILES |
COC1=CC(=C2C(=O)CC(OC2=C1)C3=CC=CC=C3)O
|
|||
InChI |
1S/C16H14O4/c1-19-11-7-12(17)16-13(18)9-14(20-15(16)8-11)10-5-3-2-4-6-10/h2-8,14,17H,9H2,1H3/t14-/m0/s1
|
|||
InChIKey |
ORJDDOBAOGKRJV-AWEZNQCLSA-N
|
|||
CAS Number |
CAS 480-37-5
|
|||
ChEBI ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug | ||||||
Acacetin | Acacia farnesiana | Click to Show/Hide the Molecular Data of This NP | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
In-vitro Model | MDA-MB-231 | CVCL_0062 | Breast adenocarcinoma | Homo sapiens | ||
T-47D | CVCL_0553 | Invasive breast carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Acacetin and Pinostrobin inhibit malignant breast epithelial cell adhesion and focal adhesion formation to attenuate cell migration. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Hexokinase-2 (HK2) | Molecule Info | [3] | |
KEGG Pathway | Glycolysis/Gluconeogenesis | Click to Show/Hide | ||
2 | Fructose and mannose metabolism | |||
3 | Galactose metabolism | |||
4 | Starch and sucrose metabolism | |||
5 | Amino sugar and nucleotide sugar metabolism | |||
6 | Neomycin, kanamycin and gentamicin biosynthesis | |||
7 | Metabolic pathways | |||
8 | Carbon metabolism | |||
9 | HIF-1 signaling pathway | |||
10 | Insulin signaling pathway | |||
11 | Type II diabetes mellitus | |||
12 | Carbohydrate digestion and absorption | |||
13 | Central carbon metabolism in cancer |
